3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Prostatic Neoplasms
6
Breast Neoplasms
4
Thyroid Neoplasms
2
Stomach Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Carcinoma, Hepatocellular
2
Adenocarcinoma Of Esophagus
2
Uterine Cervical Neoplasms
1
Thyroid Diseases
1
Thyroid Cancer, Papillary
1
Thoracic Diseases
1
Stage I Prostate Adenocarcinoma AJCC v7
1
Seroma
1
Sarcoma, Ewing
1
Salivary Gland Neoplasms
1
Recurrence
1
Polycystic Ovary Syndrome
1
Parathyroid Neoplasms
1
Parathyroid Diseases
1
Pancreatic Neoplasms
1
Oropharyngeal Neoplasms
1
Neoplasm Metastasis
1
Multiple Myeloma
1
Lymphatic Metastasis
1
Lung Neoplasms
1
Liver Neoplasms
1
Leukemia, Myeloid, Acute
1
Kidney Neoplasms
1
Infertility
1
Interventions
Sorafenib
42
Bevacizumab
26
Oxaliplatin
21
Radiosurgery
19
Gemcitabine
17
Fluorouracil
15
Hepatectomy
13
lenvatinib
12
Radiofrequency Ablation
11
Nivolumab
11
Cisplatin
11
Radiotherapy
10
Doxorubicin
10
Capecitabine
10
durvalumab
9
Leucovorin
9
Blood Specimen Collection
9
atezolizumab
8
Liver Transplantation
8
Everolimus
7
Electroporation
7
pembrolizumab
6
camrelizumab
6
Sunitinib
6
Immunohistochemistry
6
Cryosurgery
6
Carboplatin
6
tremelimumab
5
sintilimab
5
apatinib
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Liver Neoplasms
×
Congresses as Topic
×
Clear all
NCT02784353
2022-11-17
PReHeBP
Asan Medical Center
Phase NA
Completed
158 enrolled